Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression
Lily R. Aleksandrova, Yu Tian Wang, Anthony G. Phillips
Molecular Brain (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine
Panos Zanos, Kyle A. Brown, Polymnia Georgiou, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 6, pp. 1038-1050
Open Access | Times Cited: 55
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications
Jaclyn N. Highland, Panos Zanos, Lace M. Riggs, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 763-791
Open Access | Times Cited: 75
The role of neurotrophic factors in novel, rapid psychiatric treatments
Jihye Kim, Michelle He, Alina K. Widmann, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 227-245
Closed Access | Times Cited: 23
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Kyle A. Brown, Todd D. Gould
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1114-1127
Open Access | Times Cited: 13
Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
Jordi Bonaventura, Juan L. Gomez, Meghan L. Carlton, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4144-4156
Open Access | Times Cited: 31
Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants
Yating Wang, Ningning Zhang, Lingjie Liu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 594, pp. 46-56
Closed Access | Times Cited: 30
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 18
Inhibiting the activation of enteric glial cells alleviates intestinal inflammation and comorbid anxiety- and depressive-like behaviors in the ulcerative colitis mice
Yan Li, Yan Wang, Qian Sun, et al.
Neurochemistry International (2024) Vol. 178, pp. 105789-105789
Closed Access | Times Cited: 6
Ketamine induced synaptic plasticity operates independently of long-term potentiation
Michelle K. Piazza, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2024) Vol. 49, Iss. 11, pp. 1758-1766
Open Access | Times Cited: 5
Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
Philip Borsellino, Reese I. Krider, Deanna Chea, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 742-742
Open Access | Times Cited: 13
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
The curious interpretation of novel object recognition tests
Adam Swiercz, Mumeko C. Tsuda, Heather A. Cameron
Trends in Neurosciences (2025)
Closed Access
Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
Kyle A. Brown, Musa Iyiola Ajibola, Todd D. Gould
Neuropsychopharmacology (2025)
Open Access
A unified model of ketamine’s dissociative and psychedelic properties
M. Marguilho, I. Figueiredo, Pedro Castro-Rodrigues
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 14-32
Open Access | Times Cited: 20
Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology
Malwina Lisek, Ludmiła Żylińska, Tomasz Boczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8410-8410
Open Access | Times Cited: 27
A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings
Erdem Pulcu, Calum Guinea, Philip J. Cowen, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 81-87
Open Access | Times Cited: 24
S-Ketamine Exerts Antidepressant Effects by Regulating Rac1 GTPase Mediated Synaptic Plasticity in the Hippocampus of Stressed Rats
Xianlin Zhu, Fan Zhang, Yufeng You, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 1, pp. 299-314
Open Access | Times Cited: 16
The Wistar Kyoto Rat: A Model of Depression Traits
Eva E. Redei, Mallory E. Udell, Leah C. Solberg Woods, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 9, pp. 1884-1905
Open Access | Times Cited: 16
Chronic exposure to (2 R,6 R)-hydroxynorketamine induces developmental neurotoxicity in hESC-derived cerebral organoids
Zhulin Du, Zhenle Zang, Jing Luo, et al.
Journal of Hazardous Materials (2023) Vol. 453, pp. 131379-131379
Closed Access | Times Cited: 10
Translational control by ketamine and its implications for comorbid cognitive deficits in depressive disorders
Vern Lewis, Brandon Rodrigue, Emily Arsenault, et al.
Journal of Neurochemistry (2022) Vol. 166, Iss. 1, pp. 10-23
Closed Access | Times Cited: 14
The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of (R)-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC
Agnieszka Pałucha-Poniewiera, Bartosz Bobula, Anna Rafało-Ulińska
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 288-288
Open Access | Times Cited: 8
Preclinical models of treatment-resistant depression: challenges and perspectives
Magdalena Kolasa, Agata Faron‐Górecka
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1326-1340
Open Access | Times Cited: 8
Sex-specific effects of social isolation stress and ketamine on hippocampal plasticity
Jordan Logue, Kristin J. Schoepfer, Alfonso Brea Guerrero, et al.
Neuroscience Letters (2021) Vol. 766, pp. 136301-136301
Open Access | Times Cited: 19
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
Anna Onisiforou, Polymnia Georgiou, Panos Zanos
Pharmacology Biochemistry and Behavior (2023) Vol. 223, pp. 173531-173531
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top